Other Solid Tumors Terminated Phase 1 Trials for Bortezomib (DB00188)

Also known as: Other Solid Tumor

IndicationStatusPhase
DBCOND0030393 (Other Solid Tumors)Terminated1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00064636Phase I Dose Escalation Study of VELCADE Plus Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer or Other Solid TumorsTreatment